Skip to main content

Month: May 2023

AFARAK GROUP SE: PUBLICATION OF CIRCULAR

08:00 London, 10:00 Helsinki, 31 May 2023 – Afarak Group SE (“Afarak” or “the Company”) (LSE: AFRK, NASDAQ: AFAGR) AFARAK GROUP SE: PUBLICATION OF CIRCULAR Stock Exchange Release Afarak announces that, further to the announcement (Invitation to the Annual General Meeting) published earlier today, the Company has prepared the attached Circular in connection with the proposed related party transaction. The proposed related party transaction concerns combining LL-resources GmbH into Afarak as set out in the terms and conditions of the Combination Agreement. Terms and expressions in this announcement shall, unless the context otherwise requires, have the same meanings as given to them in the Circular. Circular is available also on the Company’s website at https://afarak.com/investors/shareholder-meetings/ Helsinki,...

Continue reading

Prospera Energy Inc. announces 98% increase in current assets in Q1 2023 financial results

CALGARY, Alberta, May 31, 2023 (GLOBE NEWSWIRE) — Prospera Energy Inc. (“Prospera” or the “Corporation“) (PEI: TSX-V; OF6B: FRA) Prospera announces its first quarter 2023 financial and operating results. Selected financial and operational information outlined below should be read in conjunction with the Company’s financial statements and related management’s discussion and analysis (MD&A) for the quarter ended March 31, 2023. Prospera is pleased to announce increased working capital by $7,788,265 from various sources of funding as follows:Warrants exercised provided $4,459,265 to PEI without affecting fully diluted shares. Principle investor extended matured convertible debt of $1,500,000 by two years to 2025 to allow for PEI capital development without affecting working capital. 8% debt with equity...

Continue reading

ZETADISPLAY AB (publ) INTERIM REPORT 1 JANUARY – 31 MARCH 2023

Summary January – March 2023Net sales increased by 7.5% to SEK 119.6 (111.2) million SaaS revenues increased by 6.4% to SEK 50.0 (47.0) million EBITDA amounted to SEK 3.8 (5.4) million Adjusted for non-recurring items, EBITDA amounted to SEK 10.1 (14.4) million ARR amounted to SEK 195.4 million compared with SEK 197.7 million in the previous quarter Operating profit amounted to SEK -6.5 (-4.5) million  CEO comment Continued growth in uncertain market conditions Net sales amounted to SEK 119.6 (111.2) million. SaaS revenues amounted to SEK 50.0 (47.0) million and represented 41.8 % (42.2) of net sales. EBITDA was SEK 3.8 (5.4) million. Adjusted for non-recurring items, EBITDA amounted to SEK 10.1 (14.4) million. Our first quarter was characterized by continued growth in an increasingly uncertain market. During the first quarter...

Continue reading

FRO – First Quarter 2023 Results

FRONTLINE PLC REPORTS RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2023 Frontline plc (the “Company” or “Frontline”), today reported unaudited results for the three months ended March 31, 2023: HighlightsHighest first quarter profit since 2008 of $199.6 million, or $0.90 per basic and diluted share for the first quarter of 2023. Adjusted profit of $193.3 million, or $0.87 per basic and diluted share for the first quarter of 2023. Declared a cash dividend of $0.70 per share for the first quarter of 2023. Reported revenues of $497.3 million for the first quarter of 2023. Reported spot TCEs for VLCCs, Suezmax tankers and LR2/Aframax tankers in the first quarter of 2023 were $52,500, $64,000 and $56,300 per day, respectively. For the second quarter of 2023, we estimate spot TCE on a load-to-discharge basis of $75,000 contracted for 78%...

Continue reading

Azerion makes significant progress with the consolidation and integration of previous acquisitions

Amsterdam, 31 May 2023 – Today, Azerion has shared further details on the progress made in consolidating and integrating previously acquired businesses, which led to the launch of new products, market expansions, technological improvements and expected cost savings. Azerion’s initiatives to integrate and consolidate the different technologies, teams, brands, offices and back-office activities have progressed well in Q1 2023 and are expected to result in annualized savings of at least EUR 15 million compared to January 2023 baseline. This is a significant improvement to the previously communicated expectation of at least EUR 10 million annualized savings. After its listing on Euronext Amsterdam in early 2022, Azerion completed several acquisitions, most of them during the second half of last year. Since the beginning of 2023, Azerion has...

Continue reading

Azerion publishes interim Q1 2023 results

Consolidation and integration leading to resilient revenue growth and increased profitability Highlights of Q1 2023Resilient growth in the Platform and Premium Games segments, with Net revenue of almost € 113 million, up from € 94 million in Q1 2022. Adjusted EBITDA of almost € 9 million up by 48% compared to Q1 2022, reflecting improved margins due to accelerated integration of previous acquisitions, as well as cost optimisation. Upgraded expected annualised cost savings to at least € 15 million from at least € 10 million, excluding any effects from foreign exchange. The expected savings are compared to the January 2023 baseline. Launch of Performance by Azerion, enriching campaigns across all features and platforms, driving increased performance across the full advertisement funnel. Roll out of proprietary ad format Oneskin, an integrated...

Continue reading

15/2023 Green Hydrogen Systems adjusts its EBITDA guidance for 2023

Company announcement 15/2023 Green Hydrogen Systems adjusts its EBITDA guidance for 2023 Kolding, Denmark, 31 May 2023 – Due to implementation of modifications to the A-Series electrolysers, Green Hydrogen Systems adjusts its EBITDA guidance for 2023. The adjustment is reflected in a new expectation to EBITDA for full year 2023 in the range of DKK -280 to -240 million (previously: DKK -240 to -210 million). The Company has decided to implement a number of modifications to the A-Series platform to ensure product quality and reliability. These modifications consist of changes to materials, components and production processes, which will have a negative impact on the production costs of the A-Series electrolysers. The modifications will be implemented on the current order backlog, in the assembly process as well as retrofitted on already...

Continue reading

Netcompany releases mid-term targets

Company announcement No. 09/2023                                                                                                               31 May 2023 Netcompany releases mid-term targets In connection with the upcoming Capital Markets Day on 1 June, Netcompany Group A/S (“Netcompany”) has today updated and released its financial mid-term targets to be achieved by the end of 2026. By 2026 Netcompany expects to reach the following financial results on Group levelOrganic revenue of at least DKK 8.5bn Adjusted EBITDA margin of at least 20% Accumulated Cash redistribution to shareholders of at least DKK 2bnDuring the upcoming Capital Markets Day, Netcompany will elaborate on strategic initiatives, give updates on the individual parts of the Group and discuss financial targets. Additional information For additional information, please...

Continue reading

Valneva to Present and Hold Investor Meetings at Upcoming Conferences in June

Saint-Herblain (France), May 31, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will attend the Jefferies Healthcare Conference (June 7-9 in New York), Goldman Sachs Annual Global Healthcare Conference (June 12-15 in Dana Point, California) and the Stifel European Healthcare Conference (June 28-30 in Bordeaux, France). Valneva will present and meet with institutional investors to discuss the Company’s late-stage vaccine candidate against chikungunya (VLA1553), which is currently under review by the Food and Drug Administration (FDA) with the potential to become the world’s first approved chikungunya vaccine later this year. A regulatory application has also been filed with Health Canada earlier this week1. Valneva will also discuss its Phase 3 Lyme disease...

Continue reading

Biotalys Continues to Demonstrate Strength of First Biocontrol in Latest Global Field Trials

Ghent, Belgium, May 31, 2023 (GLOBE NEWSWIRE) —  Press releaseIn total, 160 field trials were performed in 2022 Trials continue to showcase the efficacy of Biotalys’ first protein-based biocontrol Evoca™ across various high-value crops Following regulatory approval, fruit and vegetable growers will be able to use Evoca as a novel, safe and sustainable crop protection toolBiotalys (Euronext – BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for crop and food protection, today revealed the initial results of its latest field trials for its first biocontrol, Evoca*. Throughout 2022, Biotalys conducted more than 160 in-depth field trials in partnership with industry leaders like Biobest and Beck Ag across a wider variety of crops to support its product positioning in...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.